Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 2/20 | 0.47 |
| ▸ | INSR | P06213 | 1/20 | 0.47 |
| ▸ | CTSC | P53634 | 1/20 | 0.46 |
| ▸ | SYK | P43405 | 8/20 | 0.46 |
| ▸ | BRD4 | O60885 | 5/20 | 0.45 |
| ▸ | PKMYT1 | Q99640 | 1/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.43 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1936552 | 0.89 | SYK (0.55) | ALKINSRCTSCSYKBRD4 | |
| SCHEMBL2510547 | 0.79 | CAMK1D (0.47) | ALKINSRCTSCSYKBRD4 | |
| SCHEMBL764400 | 0.77 | SYK (0.72) | SYK | |
| SCHEMBL2511992 | 0.77 | CTSC (0.52) | ALKINSRCTSCSYKBRD4 | |
| SCHEMBL3136804 | 0.76 | JAK2 (0.65) | ALKINSRCTSCSYKNTRK1 | |
| SCHEMBL1936571 | 0.76 | ULK1 (0.58) | SYK | |
| SCHEMBL1937742 | 0.74 | CTSC (0.49) | ALKINSRCTSCSYKBRD4 | |
| SCHEMBL1937791 | 0.73 | CTSC (0.53) | ALKINSRCTSCSYKNTRK1 | |
| SCHEMBL1937612 | 0.73 | ALK (0.45) | ALKINSRCTSCSYKBRD4 | |
| SCHEMBL3242576 | 0.73 | CTSC (0.48) | ALKINSRCTSCSYKBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110245242-A1 | Heterocyclically Substituted Anilinopyrimides | BAYER CROPSCIENCE AG (DE) | 2011-10-06 | — | — | US | disclosed |
| EP-2331524-A1 | HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES | Bayer CropScience AG (DE) | 2011-06-15 | — | — | EP | disclosed |
| WO-2010025831-A1 | HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245242-A1 | Heterocyclically Substituted Anilinopyrimides | H1-10, POLL, PPM1D | ALK 789/4885INSR 3223/4885CTSC 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.